{"cluster": 63, "subcluster": 16, "abstract_summ": "The aim of this study was to identify and summarize in silico evidence for possible activity of Cefuroxime against SARS-CoV-2.To this end, we performed a scoping review of literature of in silico drug repurposing experiments for SARS-CoV-2 using PRISMA-ScR. We searched Medline, Embase, Scopus, Web of Knowledge, and Google Scholar for original studies published between 1st Feb, 2020 and 15th May, 2020 that screened drug libraries, and identified Cefuroxime as a top-ranked potential inhibitor drug against SARS-CoV-2 proteins.There is currently no drug that has been proven as an effective therapy for COVID-19.Due to the urgent need for effective treatment, drug repurposing is regarded as the immediate option.Thus, anti-proinflammatory cytokine drugs like Anakinra and Tocilizumab are undergoing multiple trials and some results are encouraging.There is currently a great need for effective and safe therapies directed at the disease, but no drugs are presently registered for use in COVID-19.", "title_summ": "Repurposing Drugs for the Management of Patients with Confirmed Coronavirus Disease 2019 (COVID-19).Repurposing cefuroxime for treatment of COVID-19: a scoping review of in silico studiesTreatment Considerations for COVID-19: A Critical Review of the Evidence (or Lack Thereof)Potential specific therapies in COVID-19Thalidomide-Revisited: AreCurrent evidence for directed and supportive investigational therapies against COVID-19Emerging pharmacotherapies for COVID-19.Treatment options in people with COVID19: Selecting the best armamentarium against the novel virus.COVID-19 Patients Going to Be the Latest Victims of YetAnother Theoretical Drug-Repurposing?", "title_abstract_phrases": "The aim of this study was to identify and summarize in silico evidence for possible activity of Cefuroxime against SARS-CoV-2.To this end, we performed a scoping review of literature of in silico drug repurposing experiments for SARS-CoV-2 using PRISMA-ScR. We searched Medline, Embase, Scopus, Web of Knowledge, and Google Scholar for original studies published between 1st Feb, 2020 and 15th May, 2020 that screened drug libraries, and identified Cefuroxime as a top-ranked potential inhibitor drug against SARS-CoV-2 proteins.There is currently no drug that has been proven as an effective therapy for COVID-19.There is currently a great need for effective and safe therapies directed at the disease, but no drugs are presently registered for use in COVID-19.Due to the urgent need for effective treatment, drug repurposing is regarded as the immediate option.Repurposing Drugs for the Management of Patients with Confirmed Coronavirus Disease 2019 (COVID-19).BACKGROUND Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), termed coronavirus disease 2019 (COVID-19) by the World Health Organization, is a newly emerging zoonotic agent that emerged in China in December 2019."}